Products/Active Agents Index
This index includes nomenclature terms from
Biopharmaceuticals in the U.S. and European Markets for products and their active
ingredients.
See the Chemical Index for all other ingredients, chemicals used in
processing, contaminants, etc.
See the Biological Index for bioprocessing terms.
This index includes a variety of types of nomenclature, including chemical, regulatory,
biological, and author-contrived descriptive terms (e.g., the unique short names used for products;
see the User's Guide).
This index does not include products/agents that are not the main subject of monographs (e.g., competing products and those in development discussed in monographs). Use the online database to retrieve these other products. This index is derived from a database, and is not absolutely identical to the index in the book.
- 1-139-Interferon gamma (human lymphocyte protein moiety reduced), N(sup2)-L-methionyl- -- 213
- 1-165-Erythropoietin (human clone lambda HEPOFL13 protein moiety) -- 133; 136
- 1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha -- 133; 136
- 1-165-erythropoietin (human HMR4396), glycoform 8 -- 141
- 1-25-oncostatin M (human precursor) fusion protein with CTLA-4 (antigen) (human) fusion protein with immunoglobulin G1 (human heavy chain fragment), bimolecular (146-->146')-disulfide -- 123
- 1-92-LFA-3 (antigen) (human) fusion protein with immunoglobulin G1 (human hinge-CH2-Ch3 gamma1-chain), dimer -- 227
- 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide -- 205
- 10.20588 kDa -- 156
- 104138-64-9 -- 162; 163
- 105857-23-6 -- 269
- 108153-74-8 -- 936
- 11061-68-0 -- 193
- 11061-94-2 -- 713
- 11070-73-8 -- 631
- 110942-02-4 -- 218; 219
- 11096-26-7 -- 141
- 111070-04-3 -- 112
- 111In-CYT-356 -- 312
- 1131189-02-9 -- 723
- 113427-24-0 -- 132; 133; 136
- 116094-23-6 -- 195
- 118390-30-0 -- 209
- 12.48534 kDa -- 156
- 120993-53-5 -- 182
- 121181-53-1 -- 158
- 122312-54-3 -- 132; 138
- 123774-72-1 -- 169
- 12407-79-3 -- 713
- 125-L-Serine-2-133-interleukin 2 (human reduced) -- 218; 219
- 12584-58-6 -- 633; 633
- 126161-67-9 -- 457
- 12629-01-5 -- 247; 248; 249; 250; 251; 252; 253; 254; 255; 256; 257
- 129069-19-8 -- 943
- 129805-33-0 -- 109
- 130167-69-0 -- 611
- 132-L-alanine-1-193-bactericidal/permeability-increasing protein (human) -- 106
- 133107-64-9 -- 199
- 133652-38-7 -- 268
- 13533-635-02;13533-635-04; 13533-635-10; 13533-635-12 -- 758
- 135968-09-1 -- 160
- 138068-37-8 -- 181
- 138660-99-8 -- 310
- 138661-00-4 -- 310
- 138955-26-7 -- 314
- 138955-27-8 -- 314
- 139659-92-0 -- 200
- 1,4-alpha-D-glucan glucohydrolase -- 168
- 143003-46-7 -- 615
- 143011-72-7 -- 158
- 143653-53-6 -- 240
- 143831-71-4 -- 126
- 144058-40-2 -- 313
- 145155-23-3 -- 212
- 145258-61-3 -- 210; 211
- 145464-28-4 -- 312
- 145941-26-0 -- 216; 156
- 15-L-glutamic acid-16-glycine- -- 936
- 150 kDa -- 267
- 152923-56-3 -- 222
- 154248-97-2 -- 167
- 154361-48-5 -- 307
- 154361-49-6 -- 307
- 159519-65-0 -- 933
- 16009-13-5 -- 740
- 160337-95-1 -- 197
- 161262-29-9 -- 803
- 162394-19-6 -- 226
- 165101-51-9 -- 237; 238; 239
- 169147-32-4 -- 948
- 16941-32-5 -- 165; 166
- 17-1A mAb -- 131
- 17034-35-4 -- 935
- 171656-50-1 -- 302
- 173-527-plasminogen activator (human tissue-type protein moiety reduced), 173-L-serine-174-L-tyrosine-175-L-glutamine- -- 268
- 173146-27-5 -- 220
- 174722-31-7 -- 115; 116
- 178254-26-7 -- 226
- 18.23606 +/- 400 kDa -- 133
- 18.80 kDa -- 158
- 190977-41-4 -- 945
- 192391-48-3 -- 306
- 196488-72-9 -- 628
- 198153-51-4 -- 205
- [199-Arginine,223-histidine]prepro-a-glucosidase (human)
-- 168
- 2-133-Interleukin 2 (human reduced), 125-L-serine- -- 218; 219
- 2-166-Interferon beta1 (human fibroblast reduced), 17-L-serine- -- 212
- 2-178 Interleukin-11 (human clone pXM/IL-11) -- 216
- 2-sulfo-L-iduronate 2-sulfatase -- 188
- 205923-56-4 -- 128
- 206254-79-7 -- 106
- 207748-29-6 -- 198
- 208265-92-3 -- 159
- 208921-02-2 -- 306
- 209810-58-2 -- 143
- 21.sup.A-Gly-30B.sup.a-L-13-Arg-30.sup.Bb-L-Arg-human insulin -- 197
- 210589-09-6 -- 187
- 213327-37-8 -- 301
- 214745-43-3 -- 114
- 216974-75-3 -- 275
- 219685-50-4 -- 120
- 220578-59-6 -- 118
- 222535-22-0 -- 227
- 222716-86-1 -- 949
- 225.28S melanoma monoclonal antibody F(ab')2 fragments--technetium Tc-99m radioimmune conjugate -- 309
- 225239-31-6 -- 305
- [23-methionine]-23-163-fibroblast growth factor 7 (human clone 32/49 reduced) -- 226
- 24-163 fibroblast growth factor 7 (human) -- 226
- 242138-07-4 -- 189
- 250689-71-5 -- 949
- 259074-76-5 -- 153
- 261356-80-3 -- 141
- 262434-79-7 -- 933
- 28b-L-Lysine-29b-L-proline insulin (human) -- 199
- 29.25018 kDa -- 126
- 29B-(N6-Myristoyl-L-lysine)-30B-de-L-threonineinsulin
(human) -- 196
- 3-((2-aminoethoxy)methyl)-2,5,9-trimethyl-7H-furo(3,2-g)(1)benzopyran-7-one -- 803
- 3-203-fibrolase (3-serine) (Agkistrodon contortrix recombinant) -- 153
- [30-L-asparagine,32-L-thronine,87-L-valine,88-L-asparagine,90-L-threonine]erythropoietin (human) -- 143
- 30.400 kDa -- 133; 136; 136
- 331731-18-1 -- 265
- 332348-12-6 -- 123
- 339177-26-3 -- 129
- 347396-82-1 -- 276
- 36-482-hyaluronoglucosaminidase PH20 (human) -- 186
- 37.000 kDa -- 126
- 372075-36-0 -- 217
- 37228-64-1 -- 615
- 37279-02-0 -- 112
- 37288-86-1 -- 612
- 375823-41-9 -- 223
- 39.57189 kDa -- 268
- 39433-96-0 -- 612
- [3B-B-lysine, 29 B-L-glutamic acid]insulin (human)
-- 198
- 4-sulfatase -- 105
- 420794-05-0 -- 168
- 428863-50-7 -- 266
- 433977-72-1 -- 202
- 460738-38-9 -- 225
- 477202-00-9 -- 124
- 478166-15-3 -- 202
- 488712-31-8 -- 619
- 49281-0790-01, 49281-0790-20, and 49281-0790-50 -- 561
- 49281-240-10 -- 932
- 49281-880-01 -- 409
- 495-L-Histidineglucosylceramidase (human placenta isoenzyme protein moiety) -- 167
- 49502-180-01 and 49502-180-03 -- 943
- 5'-ester of (2'-deoxy-2'-fluoro)C-Gm-Gm-A-A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-Am-Gm-(2'-deoxy-2'-fluoro)-U-Gm-Am-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)-C-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)U-Am-(2'-deoxy-2'-fluoro)U-Am-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Gm-(3'--3')-dT with ,'-[[(1S)-1-[[5-(phosphonooxy)pentyl]car-bamoyl]pentane-1,5-diyl]bis(iminocarbonyl)]bis[-methoxy-poly(oxyethane-1,2-diyl)] octacosasodium salt -- 949
- 5.808 kDa -- 192
- 50% Human Insuin Isophane Suspension, 50% Human Insulin Injection (rDNA origin) -- 192
- 50 kDa -- 310
- 501081-76-1 -- 215
- 50378-38-2 -- 187
- 50419-523-25 -- 212
- 50936-59-9 -- 188
- 52014-67-2 -- 707; 708
- 520C9x22 -- 179
- 552858-79-4 -- 105
- 55326-32-4 -- 112
- 57894-0030-01 -- 264
- 57971-58-7 -- 186
- 6.51157 kDa -- 713
- 60.430 Da kDa -- 167
- 600735-73-7 -- 233
- 60202-16-6 -- 243
- 60574-2101-02 -- 781
- 60574-4111-01 -- 245
- 615258-40-7 -- 244
- 61584-57-4 -- 112
- 63-Desulfohirudin (Hirudo medicinalis isoform HV1) -- 182
- 64365-503-01 -- 220
- 6505011052313 -- 402
-
[653-glycine][human interleukin-1 receptor accessory protein-(1-339)-peptide (extracellular domain fragment) fusion protein with human type 1 interleukin-1 receptor-(5-316)-peptide (extracellular domain fragment) fusion protein with human immunoglobulin G1-(229 C-terminal residues)-peptide (Fc fragment)], (659-659':662-662')-bisdisulfide dimer -- 215
- [653-glycine][human interleukin-1 receptor accessory protein-
(1-339)-peptide (extracellular domain fragment) fusion protein with human type 1 interleukin-1 receptor-(5-316)-peptide (extracellular domain fragment) fusion protein with human immunoglobulin G1-(229 C-terminal residues)-peptide (Fc fragment)], (659-659':662-662')-bisdisulfide dimer -- 215
- [653-glycine][human interleukin-1 receptor accessory protein-(1-339)-peptide (extracellular domain fragment) fusion protein with human type I interleukin-1 receptor-(5-316)-peptide (extracellular domain fragment) fusion protein with human immunoglobulin G1-(229 C-terminal residues)-peptide (Fc fragment)] dimer -- 215
- 677010-34-3 -- 246
- 67763-96-6 -- 201
- 679404-95-6 -- 741
- 68562-41-4 -- 200; 201
- 69 kDa outer membrane protein (69kd) -- 506; 508
- 70% Human Insuin Isophane Suspension, 30% Human Insulin Injection (rDNA origin) -- 192
- 70% NPH, Lente, Human Insulin Zinc Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) -- 193
- 745013-59-6 -- 125
- 74899-72-2 -- 795; 796
- 76543-88-9 -- 204
- 77907-69-8 -- 204
- 78690-13-8 -- 705
- 7E11-C5 -- 312
- 7E11-C5.3-GYK-DTPA -- 312
- 7E3, human-murine monoclonal antibody -- 240
- 7H-furo(3,2-g)(1)benzopyran-7-one, 3-((2-aminoethoxy)methyl)-2,5,9-trimethyl- -- 803
- 8001-27-2 -- 180
- 80295-38-1 -- 113; 714
- 8049-62-5 -- 631; 633
- 81669-57-0 -- 606; 624; 625
- 82030-87-3 -- 258
- 82115-62-6 -- 213
- 828933-51-3 -- 130
- 83869-56-1 -- 169
- 85898-30-2 -- 218
- 9000-94-6 -- 102; 706; 708
- 9001-12-1 -- 612
- 9001-27-8 -- 147; 152; 715; 716; 717; 720; 722; 724; 725; 726
- 9001-28-9 -- 727; 728; 729; 731; 732; 733; 734
- 9001-73-4 -- 622
- 9001-99-4 -- 628
- 9002-01-1 -- 624; 625
- 9003-98-9 -- 126
- 9004-09-5 -- 614
- 9004-10-8 -- 192; 193
- 9004-14-2 -- 633
- 9007-12-9 -- 110
- 9007-92-5 -- 165; 166
- 9008-11-1 -- 204; 206; 209; 794; 795; 796
- 9015-68-3 -- 609
- 90170-80-2 -- 707; 708
- 9026-93-1 -- 605
- 9041-92-3 -- 709; 710; 711; 712
- 9074-87-7 -- 112
- 9087-70-1 -- 713
- 93384-43-1 -- 601
- 96778-78-8 -- 212
- 98059-61-1 -- 213
- 98530-12-2 -- 206
- 98530-76-8 -- 243
- 99210-65-8 -- 206
- 99283-10-0 -- 170
- a specific active immunotherapeutic composed of antigen-loaded autologous antigen presenting cells designed to stimulate a T cell immune response specific for the tumor-associated antigen prostatic acid phosphatase (PAP) -- 242
- A1AT -- 710; 711
- A1PI -- 709; 710; 711; 712
- Aafact -- 719
- AAT -- 709; 710; 711; 712
- Abatacept -- 123
- Abbocath-T -- 626
- Abbokinase for Injection -- 626
- Abbokinase Open-Cath -- 626
- Abciximab -- 240
- Abetimus sodium -- 948
- Abseamed -- 135
- ABX-EGF -- 129
- ACAM2000 -- 539; 540
- Accretropin -- 249
- Acel-Imune -- 435
- Acellular Dermal Graft -- 658
- Acellular Pertussis Vaccine -- 506
- Acellular Pertussis Vaccine Adsorbed -- 505
- Acellular Pertussis Vaccine Concentrate (For Further Manufacturing Use) -- 507; 508
- Acellular pertussis vaccine plus Haemophilus influenzae type b (Hib) vaccine -- 443
- acetylaspartylglutamate dipeptidase -- 112
- acid alpha-glucosidase -- 168; 168
- acid maltase -- 168
- Actarapid -- 193
- Actemra -- 223
- ActHIB -- 455
- ActHIB Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) reconstituted with Tripedia, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed -- 443
- ActHib + Quadracel -- 445
- Actilyse -- 269
- Actimmune -- 213
- Actiplas -- 269
- Activacin -- 269
- Activase -- 269
- activated Factor VII -- 145
- activated Protein C -- 243
- activated prothrombin complex -- 705
- Ad-p53 -- 232; 233
- Ad5CMV-p53 -- 233
- Adacel -- 437
- ADAGEN Injection -- 605
- Adalimumab -- 265
- Adeno-p53 -- 233
- adenosine deaminase, monomethoxypolyethylene glycol succinimidyl L- -- 605
- Adenosine Deaminase, PEG- -- 605
- Adenovirus Vaccine, Live, Oral, Type 4 -- 401; 402
- Adenovirus Vaccine, Live, Oral, Type 7 -- 401; 403
- Adenovirus Vaccine, type 4 -- 402
- Adenovirus Vaccine, type 7 -- 403
- adenovirus vector p53 gene therapy -- 232
- adenovirus vector p53 gene therapy, recombinant -- 233
- adipogenesis inhibitory factor -- 216
- Adju-fos -- 937
- Adp53 -- 233
- Adsorbable Collagen Sponge (ACS) -- 108
- AdvaSeal -- 735
- Advate -- 148
- Advexin -- 233
- agalsidase -- 161
- Agalsidase alfa -- 162
- Agalsidase beta -- 163
- AGIF -- 216
- Agkistrodon piscivorus antivenin -- 908
- AHF -- 146; 147; 149; 150; 151; 152; 715; 716; 717; 718; 720; 721; 722; 723; 724; 725; 726; 901
- AHF-PFM -- 148
- AIG -- 744
- Albumin -- 703
- Albumin (Human) -- 703
- Albumin (Human) USP -- 703
- Albumin, rDNA -- 101
- albumin, recombinant -- 101
- Aldesleukin -- 218; 219
- Aldurazyme -- 187
- Alefacept -- 227
- Alemtuzumab -- 119
- alfa-2a interferon -- 204
- Alfanative -- 796
- Alfatronol -- 206
- Alferon N Injection -- 795
- alfimeprase -- 153
- Alglucerase -- 615
- alglucosidase alfa -- 168
- Alhydrogel -- 937
- alkaline deoxyribonuclease -- 126
- Alloderm -- 658
- Alpahrix -- 476
- alpha glucosidase -- 168
- alpha-1 antitrypsin -- 709; 710; 712
- alpha-1-Proteinase Inhibitor (Human) -- 709; 710; 711; 712
- alpha-2a interferon -- 204
- alpha-Gal A -- 161
- alpha-galactosidase -- 161; 162; 163
- alpha-L-iduronidase -- 187
- alpha-n3 interferon -- 795
- alpha-Rix -- 476
- alpha1-antitrypsin -- 710; 711
- alpha1-PI -- 710; 711
- alpha1-trypsin inhibitor -- 711
- Alphaferon -- 796
- AlphaLeukoferon -- 796
- Alphanate -- 725
- AlphaNine SD -- 733
- Alpheon -- 207
- Alronidase -- 187
- Altemol -- 795
- Alteplase, recombinant -- 269
- Alteplase USP -- 269
- alum -- 937
- aluminum hydroxide -- 937
- aluminum oxyhydroxide -- 937
- aluminum phosphate -- 937
- Aluminum-based Adjuvants -- 937
- ALX 111 -- 235
- Ambirix -- 466
- Amevive -- 227
- AMG 162 -- 244
- amorphous aluminum hydroxyphosphate -- 937
- amorphous aluminum hydroxyphosphate sulfate -- 937
- Amotosalen -- 803
- amotosalen HCl -- 803
- Amphadase -- 617
- Ampligen -- 947
- AMVISC -- 926
- AN900 -- 220
- Anakinra -- 214
- Angiomax -- 934
- Anistreplase -- 606; 623; 624; 625
- ant-CD3 -- 303
- Antegren -- 203
- Anthrax immune globulin/DVC -- 744
- Anthrax Vaccine -- 404
- Anthrax Vaccine Adsorbed -- 404
- Anthrax Vaccine, rDNA/Emergent -- 104
- Anthrax Vaccine, rDNA/VaxGen -- 103
- Anti-(human CD20 antigen) immunoglobulin G1 (human-mouse monoclonal IDEC-C2B8 ?1-chain) disulfide with human-mouse monoclonal IDEC-C2B8 ?-chain, dimer -- 115; 116
- anti-(human CD20 antigen) immunoglobulin G2a (mouse monoclonal clone B1R1 chain) disulfide with mouse monoclonal clone B1R1 x-chain, dimer -- 306
- Anti-(human interleukin 2 receptor) immunoglobulin G1 (human-mouse monoclonal CHI621 alpha1-chain) disulfide with human-mouse monoclonal CHI621 light chain, dimer -- 221
- anti-(human tumor-associated glycoprotein 72) immunoglobulin G1 (mouse monoclonal B72.3 ?1-chain) disulfide with mouse monoclonal B72.3 light chain, dimer -- 313; 314
- Anti-Carcinoembryonic Antigen Mab radioconjugate -- 307
- anti-carcinoembryonic antigen monoclonal antibody -- 304
- anti-CD20 monoclonal antibody -- 115; 116
- anti-D immunoglobulin -- 778
- anti-EpCAM x anti-CD3 -- 131
- anti-GPIIb/IIIa monoclonal antibody -- 240
- anti-hemophilic factor, cryoprecipitated -- 716
- Anti-Inhibitor Coagulant Complex -- 704; 705
- Anti-Inhibitor Coagulant Complex, Vapor Heated -- 704
- Anti-Inhibitor Coagulant/Baxter -- 704
- Anti-Inhibitor Coagulant/Nabi -- 705
- Anti-TAG-72 monoclonal antibody -- 313
- Anti-thymocyte Globulin (Equine) -- 918
- Anti-thymocyte Globulin (Rabbit) -- 917
- Anti-Tumor Associated Glycoprotein-72 Mab radioconjugate -- 314
- Anti-Typhoid Vaccine -- 560
- anti-VEGF apatamer -- 949
- anti-VEGF monoclonal antibody -- 275
- Antibody-based ImmunoTherapy (AIT) -- 301
- antigen-4(anti-CTLA-4) monoclonal antibody -- 124
- antigen-induced interferon -- 213
- Antihemophilic Factor -- 147; 149; 151; 152; 717; 718; 719; 720; 721; 722; 723; 724; 725
- Antihemophilic factor B -- 727; 728; 729; 730; 731; 733; 734
- Antihemophilic Factor Concentrate (Recombinant)(For Further Manufacturing Use) -- 146
- Antihemophilic Factor Concentrate (Recombinant)(For Further Manufacturing Use) (non-sterile drug substance in elution buffer) -- 146
- antihemophilic factor, cryoprecipitated -- 716
- Antihemophilic Factor, Human -- 147; 149; 151; 152
- Antihemophilic Factor (Human) -- 715; 717
- Antihemophilic Factor, Human -- 717
- Antihemophilic Factor (Human) -- 718
- Antihemophilic Factor, Human -- 718
- Antihemophilic Factor (Human) -- 719
- Antihemophilic Factor, Human -- 720; 721
- Antihemophilic Factor (Human) -- 722
- Antihemophilic Factor, Human -- 722
- Antihemophilic Factor (Human) -- 723
- Antihemophilic Factor, Human -- 723
- Antihemophilic Factor (Human) -- 724
- Antihemophilic Factor, Human -- 724; 725; 726
- Antihemophilic Factor (Human) -- 726
- Antihemophilic Factor (Human), Method M, Monoclonal Purified -- 721; 722
- Antihemophilic Factor (Human) Solvent Detergent/Heat Treated -- 725
- Antihemophilic Factor IX -- 144
- Antihemophilic Factor (Porcine) -- 901
- Antihemophilic Factor (Recombinant) -- 147; 149; 150; 151; 152
- Antihemophilic Factor (Recombinant), Formulated with
Sucrose -- 149; 151
- Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method -- 148
- Antihemophilic Factor USP -- 147; 149; 151; 152; 717; 720; 722; 723; 724; 725
- Antihemophilic Factor VIII -- 717; 722; 725
- Antihemophilic Factor VIII:c (see Factor VIII:C) -- 723
- Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized -- 726
- Antilymphocyte Immunoglobulin (Horse) -- 918
- Antimyeloma Mab fragments -- 309
- Antirabies Serum -- 774; 775
- Antithrombin alfa -- 102
- Antithrombin II (AT-II) -- 706
- Antithrombin III -- 102; 707; 708
- Antithrombin III (Human) -- 706; 707; 708
- Antithrombin III, rDNA -- 102
- Antithrombin III/Octapharma -- 708
- Antithrombin III/Talacris -- 707
- Antitrypsin, alpha-1 Products -- 709
- Antitrypsin, alpha-1/Baxter -- 710
- Antitrypsin, alpha-1/CSL -- 712
- antitrypsin, alpha-1/Talacris -- 711
- Antivenin (Crotalidae) antivenin -- 907
- Antivenin (Crotalidae) Fab -- 908
- Antivenin (Crotalidae) Polyvalent (equine origin) antivenin -- 907
- Antivenin (Latrodectus mactans) -- 909
- Antivenin (Micrurus fulvius) -- 910
- Antivenin (Micrurus fulvius) (equine origin) -- 910
- antivenins -- 906
- antivenoms -- 906
- Antril -- 214
- aP -- 505; 506
- APC -- 243; 243
- APC8015 [referring to primed dendritic cells] -- 242
- Apidra -- 198
- Apligraf -- 651
- Apligraf Human Skin Equivalent -- 651
- Aprotinin -- 713; 737
- Aprotinin Solution -- 713
- APSAC -- 606
- Apsaplase -- 606
- Aralast -- 710
- Aralast NP -- 710
- Aranesp -- 143
- arcitumomab -- 307
- Arilvax -- 566
- Armand-Frappier strain of BCG -- 408
- Arthrease -- 927
- arylsulfatase B -- 105
- Arylsulfatase B, rDNA -- 105
- Aryplase -- 105
- ASB -- 105
- ASP -- 609
- Asparaginase -- 607; 609; 610
- Asparaginase, E. coli/OPi -- 608
- Asparaginase, E. coli/Ovation -- 609
- Asparaginase, L- (E. coli) -- 609
- Asparaginase, monomethoxypolyethylene glycol succinimidyl L- -- 611
- Asparaginase, PEG- -- 611
- Asparaginase, reaction product with succinic anhydride, esters with polyethylene glycol, monomethyl ether -- 611
- asparagine aminohydrolase -- 607; 608; 609
- AT-III -- 707; 708
- AT-III, recombinant -- 102
- ATCC PTA-1883 -- 301
- Atenotiv -- 708
- Atgam Sterile Solution -- 918
- Atnativ -- 708
- ATryn -- 102
- Attenuvax -- 491
- augmerosen -- 945
- autologous, blood cell-derived anti-inflammatory proteins -- 742
- Autologous Cultured Chondrocytes -- 650
- Autoplex T -- 705
- AVA -- 404
- Avakine -- 264
- Avastin -- 275
- Avaxim -- 465
- avian influenza vaccine -- 485; 486; 487; 488
- Avonex -- 210
- B,D-fructofuranoside fructohydrolase -- 629
- B-2036 -- 259
- b-CAPSA-1 -- 453
- B-cell non-Hodgkin's lymphoma autologous immunoglobulin idiotype-KLH conjugate vaccine -- 271
- B-cell non-Hodgkin's lymphoma autologous tumor protein idiotype-KLH conjugate vaccine -- 417
- B-domain deleted recombinant Factor VIII -- 150
- B-type natriuretic peptide, recombinant -- 231
- B02BD02 -- 146
- B1 therapy -- 306
- B2036-PEG -- 259
- B28 asp regular human insulin analog -- 195
- B28-Asp-insulin, recombinant -- 195
- B29Lys(epsilon-tetradecanoyl), desB30 human insulin -- 196
- B29Lys-myristoyl.des-B30 human insulin -- 196
- B43.13 -- 301
- B72.3 -- 313
- BabyBIG -- 747
- BAC -- 736
- BAC2 -- 736
- Bacille Calmette Guerin (BCG), live -- 410
- Bacille Calmette Guerin vaccine -- 411
- Bacillus anthracis protective antigen, recombinant -- 103
- Bacillus anthracis protective antigen vaccine, recombinant -- 104
- Bacillus Calmette Guerin (BCG), live -- 410
- Bacillus Calmette-Guerin (BCG), substrain Montreal -- 408
- Bacillus of Calmette and Guerin (BCG), live -- 408; 409; 410; 411; 412
- Bacterial Antigens/Delmont -- 405
- Bacterial Antigens/Mixed -- 406
- Bactericidal/permeability-increasing Protein, rDNA -- 106
- Basic pancreatic trypsin inhibitor -- 713
- Basiliximab -- 221
- BAT -- 911; 912
- BAY-w-6240 -- 149
- Bayer A-128 -- 713
- BayGam -- 758
- BayHep B -- 752
- BayRab -- 775
- BayRho-D -- 777
- BayTet -- 785
- BCG Live -- 408; 409; 410
- BCG Live/GSK -- 408
- BCG Live/Sanofi -- 409
- BCG Live/Schering-Plough -- 410
- BCG Vaccine -- 411
- BCG Vaccine for Percutaneous Use -- 411
- BCG Vaccine USP -- 411
- BCG Vaccine/Akzo -- 411
- BCG Vaccine/Sanofi -- 412
- Bcl-2 Antisense Drug -- 945
- BDDrFVIII -- 150
- Bebulin VH Immuno -- 734
- becaplermin -- 237; 238; 239
- Becaplermin concentrate -- 238
- Begrivac -- 473
- BeneFIX -- 144
- Beractant -- 941
- Beromun -- 263
- beta-D-glucosyl-N-acylsphingosine glucohydrolase -- 167; 615
- beta-Glucocerebrosidase -- 167; 615
- beta-TCP -- 237
- beta-tricalcium phosphate -- 237
- Betaferon -- 212
- Betaseron -- 212
- bevacizumab -- 275
- Bexxar -- 306
- BG 8967 -- 934
- BG-9015 -- 209; 210; 211
- BG-9273 -- 227
- BG-9418 -- 209
- BG-9712 -- 227
- BG1000 and BG2000 -- 900
- BG9216 -- 209
- BG9418 -- 209; 209
- BI 61.012 -- 169
- BIAVAX -- 534
- BIG-IV -- 747; 911
- BIKEN PT/FHA -- 507
- Bilayered Cellular Matrix -- 656
- Binocrit -- 139
- Bio-Tropin -- 256
- Bioclate -- 152
- BioGlue Surgical Adhesive -- 900
- Biological Active Component -- 736
- Biological Intermediate 777 -- 794
- BioLon -- 927
- BioThrax -- 404
- BiovaxID -- 417
- Biozyme-C -- 612
- bird flu vaccine -- 486; 488
- bird flu vaccines -- 484
- bivalirudin -- 934
- Black Widow Spider Antivenin, Equine Origin -- 909
- Blood Cells, Human Red -- 806
- Blood Cells, Red -- 806
- Blood Cells, Red USP -- 806
- Blood coagulation factor IX -- 728; 729; 731; 733; 734
- Blood, Whole -- 702
- Blood, Whole and Blood Products -- 702
- Blood, Whole Human -- 702
- Blood, Whole USP -- 702
- Blood-coagulation factor VIII -- 715
- Blood-coagulation factor VIII, complex -- 147; 151; 152; 717; 720; 721; 721; 722; 723; 725; 726
- Blood-coagulation factor XIV -- 243
- BM-06022 -- 268
- BM-102 -- 105
- BMP-2 -- 108
- BMP-7 -- 109
- BMS-188667 -- 123
- Bone Morphogenetic Protein-2 -- 108
- bone morphogenetic protein-2, rDNA -- 108
- bone morphogenic protein-7, rDNA -- 109
- BoNT-B -- 604
- Boostrix -- 436
- Bordetella pertussis 69 kDa outer membrane protein (69kd) -- 506
- Bordetella pertussis toxoid, recombinant -- 236
- Bordetella pertussis type 2 fimbria -- 506; 508
- Borrelia burgdorfi outer surface protein A (OspA), recombinant -- 229; 230
- BotB -- 604
- Bothrops atrox antivenin -- 907
- Botox Cosmetic -- 601
- BOTOX Purified Neurotoxin Complex -- 601
- Botulinum immune globulin/CA -- 747
- botulinum toxin -- 600
- Botulinum Toxin A/Allergan -- 601
- Botulinum Toxin A/Ipsen -- 602
- Botulinum Toxin A/Merz -- 603
- botulinum toxin equine immune globulin -- 911; 912
- botulinum toxin human immune globulin -- 747
- botulinum toxin type A complex -- 602
- Botulinum Toxin Type B -- 604
- Botulinum Toxin Type B Injectable Solution -- 604
- Botulinum Toxoid -- 413
- Botulinum Toxoid ABCDE -- 413
- Botulism Antitoxin -- 912
- Botulism Antitoxin (BAT) -- 413
- Botulism Antitoxin/A,B,E -- 912
- Botulism antitoxin/A-G -- 911
- botulism immune globulin intravenous -- 747; 911
- Botulism Immune Globulin Intravenous (Equine) -- 911
- Botulism Immune Globulin Intravenous (Human) -- 747
- Bovine Albumin Glue -- 900
- bovine hyaluronidase -- 616
- bovine insulin -- 631
- bovine lung surfactant -- 941; 942
- bovine serum albumin (BSA) and glutaraldehyde -- 900
- BRL 26921 -- 606
- Buffered Regular Human Insulin Injection (rDNA origin) -- 193
- C-4 -- 310
- c-erbB2 monoclonal antibody -- 179
- C1 esterase inhibitor -- 113
- C1-esterase Inhibitor -- 714
- C1-INH -- 714
- C153H225N43O49S -- 166
- C1736H2653N499O522S22 -- 268
- C1INH -- 714
- C225 -- 128
- C2532H3843N671O711S16 -- 167
- C2569H3894N746O781S40 -- 269
- C256H381N65O76S6 -- 633
- C257H383N65O77S6 -- 192
- C284H432N84O79S7 -- 713
- C287H440N80O111S6 -- 181
- C437H682N122O134S13 -- 156
- C538H833N145O171S13 -- 156
- C639H1002N169O196S8 -- 169
- C690-H1115-N177-O203-S6 -- 218
- C734H1166N204O216S5 -- 213
- c7E3 -- 240
- c7E3 Fab fragment -- 240
- C809H1301N229O240S5 -- 141
- C809H1301N229OO240S5 -- 133; 136
- C845H1339N223O243S9 -- 158
- C849H1348N223O244S9,(C2H4O)n -- 159
- C860H1353N227S9 -- 204
- C908H1406N246O252S7 -- 210; 211
- C990-H1528-N262-O300-S7 -- 252
- C990H1528N262O300S7 -- 247
- CA125 Mab Fab2ÐIn111 radioconj. -- 302
- cA2 -- 264
- cachectin receptor -- 267
- CAIV-T -- 191
- CAIV-T (H5N1) -- 486
- Calcitonin -- 110
- Calcitonin, rDNA -- 110
- calcitonin-salmon (rDNA origin) -- 110
- calfactant -- 942
- calicheamicin-CD33 monoclonal antibody conjugate -- 118
- CAMPATH -- 119
- CAMPATH-1 -- 119
- CAMPATH-1H -- 119
- Cancer vaccine, poxvirus vectors, rDNA -- 111
- Canferon -- 204
- Capromab -- 312
- Capromab Pendetide -- 312
- carboxypeptidase G2 -- 112
- carcinoembryonic antigen monoclonal antibody -- 304
- carcinoembryonic antigen monoclonal antibody Fab' fragment--Technetium-99m radioimmune conjugate -- 307
- Carimune -- 770
- Carticel -- 650
- cartilage cells, autologous -- 650
- Cascabel antivenin -- 907
- Cathflo Activase -- 269
- catumaxomab -- 131
- CC49 Mab---Indium I 125 radioimmune conjugate -- 315
- CC49 Mab-In131 -- 315
- CC49 tumor Associated Glycoprotein-72 monoclonal antibodyÐIndium In 111 radioimmune conjugate -- 315
- CCS -- 656
- CCSV -- 539
- CD11a Mab, rDNA -- 114
- CD11a monoclonal antibody, recombinant -- 114
- CD15 MabÐTc 99m radioconj. -- 305
- CD15 monoclonal antibody--Technicium TC99M radioimmune conjugate -- 305
- CD152 antigenÐimmunoglobulin G1 fragment fusion protein -- 123
- CD20 Mab, rDNA -- 115
- CD20 Mab, rDNA conc. -- 116
- CD20 Mab, rDNAÐI 131 radioconj. -- 306
- CD20 Mab, rDNA/Y-90 & In-111 radioconj. -- 117
- CD20 monoclonal antibody Fab fragment/Tc 99m -- 311
- CD20 monoclonal antibody I-131 radioimmune conjugate -- 306
- CD20 monoclonal antibody, recombinant -- 115; 116
- CD20 monoclonal antibody, recombinant--Yttrium Y 90 radioimmune conjugate -- 117
- CD25 monoclonal antibody -- 221
- CD3 Mab -- 303
- CD33 immunotoxin, rDNA -- 118
- CD33 monoclonal antibody/N-acetyl-gamma calicheamicin conjugate -- 118
- CD34+ stem cell selection system -- 701
- CD52 Mab, rDNA -- 119
- CD52 monoclonal antibody, humanized -- 119
- CDP-870 -- 266
- CDP870 -- 266
- CEA -- 653
- CEA Mab, conc. -- 304
- CEA Mab Fab' radioconj. -- 307
- CEA monoclonal antibody -- 304
- CEA-Scan -- 307
- Cell Cultured Smallpox Vaccine -- 539
- CenteoRx -- 240
- CentTNF -- 264
- CEP 151 -- 201
- CEP-151 -- 200; 201
- CEPRATE SC -- 701
- Ceprotin -- 804
- CERA -- 142
- Ceramidase, glucosyl- -- 615
- Ceramidase, glucosyl ((human placenta isoenzyme protein moiety) 495-L-histidine- -- 167
- Ceredase -- 615
- Cerezyme -- 167
- Certiva -- 434
- Certiva-EU -- 434
- certolizumab pegol -- 266
- Cervarix -- 185
- Cetorå -- 714
- CetorA -- 714
- cetuximab -- 128
- CGP39393 -- 182
- chickenpox vaccine -- 564
- chimeric 225 -- 128
- chimeric anti-Tac monoclonal antibody -- 221
- chimeric IgG1 anti-human TNF MAb cA2 -- 264
- ChimeriVax-JE -- 224
- ChiRhoStim -- 936
- chloro(7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N(21),N(22),N(23),N(24)) ferrate(2-) dihydrogen -- 740
- chlorohemin -- 740
- chloroprotoporphyrin -- 740
- cholera toxin B subunit, recombinant (rCTB) -- 415
- cholera vaccine -- 414
- Cholera Vaccine (rDNA)/SBL -- 415
- Cholera Vaccine USP -- 414
- Cholera Vaccine/Wyteth -- 414
- Chondrocytes, autologous -- 650
- chondroitin 4-sulfatase -- 105
- chondroitinase -- 105
- chondroitinsulfatase -- 105; 188
- choriogonadotropin alfa -- 172
- chorionic gonadotropin, recombinant -- 172
- chRFT5 -- 221
- Christmas factor -- 727; 728; 729; 731; 732; 733; 734
- Cimzia -- 266
- Cinryze -- 714
- cintredekin besudotox -- 217
- Click.easy -- 257
- Clostridium botulinum toxin -- 600
- Clostridium botulinum toxin human immune globulin -- 747
- Clostridium botulinum toxin immune globulin F(ab')2 fragments, equine -- 911
- Clostridium botulinum toxin type A -- 602; 603
- Clostridium botulinum toxin type A, Hall strain -- 601
- Clostridium botulinum toxin type B -- 604
- Clostridium botulinum toxin types A, B, and E immune globulin F(ab')2 fragments, equine -- 912
- Clostridium botulinum toxoids A, B, C, D and E -- 413
- Clostridium tetani tetanospasmin, inactivated -- 543
- Clostridium tetani toxin, inactivated -- 543; 544; 545
- Clostridium tetani toxin, inactivated (see tetanus toxoid entries) -- 547
- clostridopeptidase A -- 612
- CMA-676 -- 118
- CMV Antisense Drug -- 946
- CMV High Titer Fraction II+III Paste (For Further Manufacturing Use) -- 750
- CMV Immune Globulin conc. -- 750
- CMV Immune Globulin/CSL -- 748
- CMV-IGIV -- 748; 749
- CNJ-016 -- 789
- Coagulation Factor IX (Human) -- 727; 731; 732
- Coagulation Factor IX (Human) Solvent Detergent Treated/Virus Filtered -- 733
- Coagulation Factor IX (Recombinant) -- 144
- Coagulation Factor VIIa (Recombinant) -- 145
- CoEase -- 926
- Colaspase -- 609
- Cold Adapted Influenza Vaccine (Liquid Formulation) -- 191
- Cold Adapted Influenza Vaccine (Liquid Formulation) (H5N1 formulation) [recombinant] -- 486
- Collagen, human -- 924
- collagen/thrombin gel -- 922
- collagen/thrombin/Plasma spray -- 923
- Collagenase -- 612
- Collagenase ABC -- 612
- Colony-stimulating factor 2 (human clone pHG25 protein moiety), 23-L-leucine -- 169
- Colony-stimulating factor 2 (human clone pHG25 protein
moiety reduced) -- 170
- colony-stimulating factor (human clone 1034) , N-L-methionyl- -- 158
- colony-stimulating factor-2 -- 169
- Combined diphtheria, tetanus, acellular pertussis, and hepatitis B recombinant vaccine -- 438
- Combined Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, inactivated Poliovirus and Haemophilus influenzae type b vaccine -- 439
- complement C1 esterase inhibitor, plasma-derived -- 714
- complement C1 esterase inhibitor, re-combinant, transgenic rabbits -- 113
- Complement C5 Mab, rDNA -- 120
- complement C5 monoclonal antibody, recombinant -- 120
- Composite Cultured Skin -- 656
- Compound Insulin Zinc Suspension -- 631; 633
- COMVAX -- 460
- conjugase -- 112
- consensus interferon -- 209
- Continuous Erythropoietin Receptor Activator -- 142
- cool.click -- 257
- Copegus -- 205
- Cordase -- 612
- corifollitropin alfa -- 122
- Corifollitropin alfa, rDNA -- 122
- Corynebacterium diphtheriae vaccine -- 419
- CosmoDerm -- 924
- CosmoPlast -- 924
- CoStasis Surgical Hemostat -- 923
- cowpox virus immune globulin -- 788
- CP.sub.10/5/5/3 -- 430
- CP-675,206 -- 125
- CP-675206 -- 125
- CPG2 -- 112
- Crescormon -- 252; 254
- Crisantaspase -- 609; 610
- CroFab -- 908
- CROSSEAL -- 736
- CroTAb -- 908
- Crotalidae Polyvalent Immune Fab (Ovine) -- 908
- Crotalus adamanteus antivenin -- 907; 908
- Crotalus atrox antivenin -- 907; 908
- Crotalus durissus antivenin -- 907
- Crotalus scutulatus antivenin -- 908
- CryoLife BioGlue Surgical Adhesive -- 900
- cryoprecipitate plus thrombin, autologous -- 739
- Cryoprecipitated AHF (Anti-Hemophilic Factor) -- 716
- CryoSeal Fibrin Sealant System -- 739
- CryoSeal FS System -- 739
- CSS -- 739
- CTAA16.88 Mab, rDNAÐTc 99m radioconj. -- 121
- CTAA16.88 monoclonal antibodyÐtechnetium Tc-99m radioimmune conjugate -- 121
- CTAP-III -- 239
- CTLA-4 Mab, rDNA/Pfizer -- 125
- CTLA4 Mab, rDNA/Medarex -- 124
- CTLA4-Ig, rDNA -- 123
- Cultured Autologous Keratinocytes Service -- 653
- cultured epidermal autografts (CEA) -- 653
- Cumulase -- 186
- Curosurf -- 943
- CuttActive -- 711
- Cymetra -- 658
- cyroprecipitate -- 716
- CYT-063 -- 312
- CYT-099 -- 313; 314
- CYT-099ÐGYK-DTPA.HCl -- 314
- CYT-099 (MAb B72.3) murine monoclonal antibody -- 314
- CYT-351 -- 312
- CYT-356 -- 312
- CytoGam -- 748
- CytoGam Liquid Formulation Solvent Detergent Treated -- 748
- cytomegalovirus immune globulin concentrate -- 750
- Cytomegalovirus Immune Globulin Intravenous (Human) -- 748; 749
- CytoMune-IV -- 748
- Cytopharm -- 795
- Cytotect -- 749
- cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) monoclonal antibody, recombinant -- 124; 125
- cytotoxic T-lymphocyte-associated antigen 4Ðimmunoglobulin G1 fragment fusion protein -- 123
- D2E7 -- 265
- DAA -- 243
- DAB389IL-2 -- 220
- Dacliximab -- 222
- Daclizumab -- 222
- Daptacel -- 430
- darbepoetin alfa -- 143
- DAT -- 916
- DCVax-Brain -- 416
- Deaminase, adenosine, cattle, reaction product with succinic anhydride, esters with polyethylene glycol mon-methyl ether -- 605
- DECAVAC -- 555
- Dendritic Cell Vaccine, Personalized/DCVax -- 416
- denileukin diftitox -- 220
- denosumab -- 244
- denV endonuclease V -- 260
- deoxyribonuclease (human clone 18-1 protein moiety) -- 126
- deoxyribonuclease I -- 126
- deoxyribonucleic acid, d(C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A), 5-'ester with 1,2-ethanediylbis(oxy-2,1-ethanediyl) bis(2-(21,21-dihydroxy-4,11-dioxo-20-oxa-13-thia-3,10-diaza-21-phosphaheneicos-1-yl)-23,23-dihydroxy-6,13-dioxo-22-oxa-15-thia-2,5,12-triaza-23-phosphatricosanoate) (4:1), P,P',23,23'-tetraoxide, complex with deoxyribonucleic acid d(T-G-T-G-T-G-T-G-T-G-T-G-T-G-T-G-T-G-T-G) (1:1), hexapentacontajextasodium salt -- 948
- Dermagraft -- 652
- Dermagraft-TC -- 657
- des-alanyl-1, serine-125 interleukin-2 -- 218; 219
- des-Pro IL-11 -- 216
- desirudin -- 182
- desulfatohirudin, recombinant -- 182
- desulfohirudin, recombinant -- 181
- Dial-A-Dose Somatropin Delivery Devices -- 253
- dibotermin alfa -- 108
- Digibind -- 913
- DigiFab -- 914
- Digitalis Antidot -- 915
- Digoxin Immune Fab (Ovine) -- 913; 914; 915
- Digoxin Immune Globulin, ovine Fab -- 913
- Digoxin Immune Globulin, ovine Fab/Protherics -- 914
- Digoxin Immune Globulin, ovine Fab/Roche -- 915
- Dimericine -- 260
- Diphtheria and Tetanus Toxoids Adsorbed USP (For Pediatric Use) -- 424
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined -- 441
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed -- 432; 433; 434; 435
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP) -- 430
- Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed USP (For Pediatric Use) -- 447
- Diphtheria and Tetanus Toxoids and Pertussis Vaccine Combined Aluminum Phosphte Adsorbed -- 449
- Diphtheria and Tetanus Toxoids Combined Aluminum Phosphate Adsorbed -- 426
- Diphtheria Antitoxin -- 916
- Diphtheria Antitoxin USP -- 916
- Diphtheria Antitoxin USP (Purified, Concentrated Globulin - EQUINE) -- 916
- diphtheria immune globulin F(ab')2 fragments, equine -- 916
- diphtheria, tetanus, acellular pertussis, and hepatitis B recombinant vaccine -- 438
- Diphtheria, Tetanus, acellular Pertussis, Hepatitis B recombinant (adsorbed), inactivated Poliomyelitis vaccine -- 442
- Diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted -- 440
- Diphtheria, tetanus and hepatitis B (recombinant) vaccine, adsorbed -- 428
- diphtheria, tetanus, pertussis, recombinant hepatitis B virus, Haemophilus influenzae type b, and Neisseria meningitides serogroups A and C vaccine -- 452
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed -- 431
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed & Haemophilus b Conjugate Vaccine (Diphtheria CRM197 Protein Conjugate) -- 444
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed plus Haemophilus influenzae type b (Hib) vaccine plus Poliovirus Vaccine Inactivated (Human Diploid Cell) -- 445
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed plus plus Poliovirus Vaccine Inactivated (Human Diploid Cell) -- 446
- Diphtheria & Tetanus Toxoids Adsorbed -- 421; 423; 424; 425; 426; 427
- Diphtheria & Tetanus Toxoids Adsorbed Combined Bulk (For Further Manufacturing Use) -- 422
- Diphtheria & Tetanus Toxoids Adsorbed Purogenated for Pediatric Use -- 426
- Diphtheria & Tetanus Toxoids Adsorbed USP (For Pediatric Use) -- 423
- Diphtheria & Tetanus Toxoids Adsorbed/Wyeth -- 421
- Diphtheria & Tetanus Toxoids Alum Precipitated and Pertussis Vaccine Combined -- 450
- Diphtheria & Tetanus Toxoids Aluminum Phosphate Adsorbed -- 425
- Diphtheria & Tetanus Toxoids Combined Aluminum Phosphate Precipitated -- 427
- Diphtheria & Tetanus Toxoids, conc. -- 422
- Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed -- 448; 449; 450
- Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed & Haemophilus b Conjugate Vaccine (Diphtheria CRM197 Protein Conjugate) -- 451
- Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed USP -- 449
- Diphtheria & Tetanus Toxoids & Pertussis Vaccine Aluminum Phosphate Adsorbed -- 448
- Diphtheria & Tetanus Toxoids/BioPort -- 425
- Diphtheria & Tetanus Toxoids/Lederle -- 426
- Diphtheria & Tetanus Toxoids/Mass. -- 427
- Diphtheria & Tetanus Toxoids/Sanofi Canada -- 423
- Diphtheria & Tetanus Toxoids/Sanofi USA -- 424
- Diphtheria Toxoid Adsorbed -- 419
- Diphtheria Toxoid Aluminum Phosphate Adsorbed -- 419
- Diphtheria Toxoid Concentrate (For Further Manufacturing Use) -- 420
- Diphtheria Toxoid/BioPort -- 419
- Diphtheria Toxoid/Statens -- 420
- DNA, d(P-thio)(T-C-T-C-C-C-A-G-C-G-T-G-C-G-C-C-A-T) -- 945
- DNA, d(T-G-T-G-T-G-T-G-T-G-T-G-T-G-T-G-T-G-T-G), compd. with NDA d-(C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A) 1,2-ethanediylbis(oxy-2,1-ethanediyl) bis(2-(21,21-dihytdroxy-21-oxido-4,11-dioxo-20-oxa-13-thia-3,10-diaza-21-phosphaheneicos-1-yl)-23,23-dihydroxy-23-oxido-6,13-dioxo-22-oxa-15-thia-2,5,12-triaza-23-phosphatricosanoate) (1:1), hexapentacontahectasodium salt -- 948
- DNase -- 126
- DNase, rDNA -- 126
- Dompe (beta) -- 210
- dornase alfa -- 126
- double stranded oligonucleotide (dsDNA) B-cell epitopes -- 948
- DP-178 -- 933
- DRN 4925 -- 310
- drotrecogin Aafa (activated) -- 243
- DRX005B-BSPC -- 162
- Dryvax -- 536
- DT vaccine -- 422; 423; 424; 425; 426; 427
- DT-HBV, rDNA -- 428
- DTaP vaccine -- 430; 431; 433; 435
- DTaP Vaccine/Chiron -- 432
- DTaP Vaccine/GSK -- 433
- DTaP Vaccine/Lederle -- 435
- DTaP Vaccine/NAVA -- 434
- DTaP Vaccine/Sanofi Canada -- 430
- DTaP Vaccine/Sanofi USA -- 431
- DTaP-HBV, rDNA -- 438
- DTaP-HBV, rDNA-Hib-IPV/GSK -- 439
- DTaP-HBV, rDNA-Hib-IPV/Sanofi -- 440
- DTaP-HBV, rDNA-IPV/EU -- 442
- DTaP-HBV, rDNA-IPV/GSK -- 441
- DTaP-HBV-IPV -- 441; 442
- DTaP-Hib -- 443
- DTaP-Hib Vaccine/Sanofi -- 443
- DTaP-Hib Vaccine/Wyeth -- 444
- DTaP-Hib-Polio Vaccine/Sanofi -- 445
- DTaP-IPV/GSK -- 446
- DTaP3-CB -- 432
- DTP, Hib, Men A/C, HBV, rDNA vaccine -- 452
- DTP & Hib Vaccine/Lederle -- 451
- DTP vaccine -- 447; 448; 449; 450
- DTP Vaccine/Aventis -- 447
- DTP Vaccine/BioPort -- 448
- DTP Vaccine/Lederle -- 449
- DTP Vaccine/Wyeth -- 450
- DTPa -- 430; 431; 432; 433; 434; 435; 436; 437; 444
- dTpa booster/GSK -- 436
- dTpa booster/Sanofi -- 437
- DTPa-HIb -- 443
- Dukoral -- 415
- Duploject -- 737
- DX-88 -- 225
- DynaStat Surgical Hemostat -- 923
- Dynepo -- 141
- Dysport -- 602
- E.C. 1.7.3